OptiBiotix Health (LON:OPTI – Get Free Report) issued its quarterly earnings data on Thursday. The company reported GBX (1.52) earnings per share for the quarter, Digital Look Earnings reports. OptiBiotix Health had a negative net margin of 333.62% and a negative return on equity of 52.92%.
OptiBiotix Health Price Performance
LON OPTI traded down GBX 0.61 on Thursday, reaching GBX 5.99. The stock had a trading volume of 985,289 shares, compared to its average volume of 354,914. OptiBiotix Health has a 1-year low of GBX 4.50 and a 1-year high of GBX 12.25. The company has a market cap of £6.19 million, a P/E ratio of -1.56 and a beta of 1.82. The firm has a fifty day moving average of GBX 5.80 and a two-hundred day moving average of GBX 5.74.
About OptiBiotix Health
OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.
OptiBiotix is also developing its own range of consumer supplements and health products.
Featured Articles
- Five stocks we like better than OptiBiotix Health
- Banc of California Bets on Short-Term Pain
- Enterprise AI to Boost Broadcom’s Software Business? What Industry Data Shows
- IonQ and NVIDIA Just Cracked a Major Quantum Computing Bottleneck
- This Gold ETF Turns a Non-Yielding Asset Into Monthly Income—But There’s a Catch
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.
